BackSpruce Biosciences Overview
Spruce Biosciences Inc

Spruce Biosciences Target Price

Analysts' average 12-month price target for Spruce Biosciences is $140.

Get informed when a big investor buys or sells

+ Follow

Share Price

$47.07

Average Target Price

$137.67192.5% upside

3 analysts in the last 4 months

High: $150 | Low: $123

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-16GuggenheimDebjit Chattopadhyay$123161.3% upsideOpen
2026-06-01H.C. Wainwright$150218.7% upsideOpen
2026-04-27Craig-HallumAlbert Lowe$140197.4% upsideOpen
2025-12-23Oppenheimer$283501.2% upsideOpen
2025-11-11JMP Securities$259450.2% upsideOpen
2025-10-28JMP Securities$254439.6% upsideOpen
2025-10-21Leerink Partners$160239.9% upsideOpen

Spruce Biosciences (SPRB) FAQ

As of the most recent data, SPRB shows a target price of $140. Scroll down for historical charts and peer comparison views.

If Spruce Biosciences moved to the average analyst target of $140, shares would be roughly 192.5% higher than $47.07. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Spruce Biosciences's earnings trajectory.

Besides this target price page, Stockcircle has Spruce Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $140) with ownership activity and broader fundamentals.

Spruce Biosciences's target price is $140; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.